Annual Revenue
$52.55 M
+$6.99 M+15.33%
December 31, 2023
Summary
- As of February 7, 2025, XGN annual revenue is $52.55 million, with the most recent change of +$6.99 million (+15.33%) on December 31, 2023.
- During the last 3 years, XGN annual revenue has risen by +$10.57 million (+25.19%).
- XGN annual revenue is now at all-time high.
Performance
XGN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$12.51 M
-$2.56 M-16.97%
September 30, 2024
Summary
- As of February 7, 2025, XGN quarterly revenue is $12.51 million, with the most recent change of -$2.56 million (-16.97%) on September 30, 2024.
- Over the past year, XGN quarterly revenue has dropped by -$909.00 thousand (-6.78%).
- XGN quarterly revenue is now -16.97% below its all-time high of $15.06 million, reached on June 30, 2024.
Performance
XGN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$55.75 M
-$909.00 K-1.60%
September 30, 2024
Summary
- As of February 7, 2025, XGN TTM revenue is $55.75 million, with the most recent change of -$909.00 thousand (-1.60%) on September 30, 2024.
- Over the past year, XGN TTM revenue has increased by +$4.13 million (+8.00%).
- XGN TTM revenue is now -1.60% below its all-time high of $56.66 million, reached on June 30, 2024.
Performance
XGN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
XGN Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.3% | -6.8% | +8.0% |
3 y3 years | +25.2% | +2.1% | +15.5% |
5 y5 years | +62.0% | +16.1% | +41.1% |
XGN Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +15.3% | -17.0% | +64.4% | -1.6% | +29.8% |
5 y | 5-year | at high | +30.1% | -17.0% | +64.4% | -1.6% | +42.3% |
alltime | all time | at high | +5574.7% | -17.0% | +1237.7% | -1.6% | +5862.7% |
Exagen Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $12.51 M(-17.0%) | $55.75 M(-1.6%) |
Jun 2024 | - | $15.06 M(+4.5%) | $56.66 M(+1.7%) |
Mar 2024 | - | $14.41 M(+4.7%) | $55.73 M(+6.1%) |
Dec 2023 | $52.55 M(+15.3%) | $13.77 M(+2.6%) | $52.55 M(+1.8%) |
Sep 2023 | - | $13.42 M(-5.1%) | $51.62 M(-2.5%) |
Jun 2023 | - | $14.14 M(+25.9%) | $52.93 M(+14.1%) |
Mar 2023 | - | $11.23 M(-12.5%) | $46.40 M(+1.8%) |
Dec 2022 | $45.56 M(-5.7%) | $12.84 M(-12.8%) | $45.56 M(+0.3%) |
Sep 2022 | - | $14.73 M(+93.6%) | $45.41 M(+5.8%) |
Jun 2022 | - | $7.61 M(-26.8%) | $42.94 M(-10.7%) |
Mar 2022 | - | $10.39 M(-18.1%) | $48.11 M(-0.4%) |
Dec 2021 | $48.30 M(+15.1%) | $12.69 M(+3.6%) | $48.30 M(+0.0%) |
Sep 2021 | - | $12.25 M(-4.1%) | $48.28 M(+3.2%) |
Jun 2021 | - | $12.77 M(+20.6%) | $46.80 M(+8.9%) |
Mar 2021 | - | $10.59 M(-16.4%) | $42.98 M(+2.4%) |
Dec 2020 | $41.98 M | $12.67 M(+17.6%) | $41.98 M(+6.2%) |
Sep 2020 | - | $10.78 M(+20.4%) | $39.52 M(+0.9%) |
Jun 2020 | - | $8.95 M(-6.6%) | $39.19 M(-3.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $9.58 M(-6.2%) | $40.71 M(+0.8%) |
Dec 2019 | $40.39 M(+24.5%) | $10.21 M(-2.2%) | $40.39 M(+1.4%) |
Sep 2019 | - | $10.44 M(-0.3%) | $39.81 M(+5.9%) |
Jun 2019 | - | $10.47 M(+13.1%) | $37.60 M(+38.6%) |
Mar 2019 | - | $9.26 M(-4.0%) | $27.12 M(+51.8%) |
Dec 2018 | $32.44 M(+21.0%) | $9.64 M(+17.2%) | $17.86 M(+117.2%) |
Sep 2018 | - | $8.22 M(+84.8%) | $8.22 M(-54.2%) |
Dec 2017 | $26.81 M(+49.4%) | - | - |
Dec 2015 | $17.95 M(+53.9%) | $4.45 M(-4.5%) | $17.95 M(+1.2%) |
Sep 2015 | - | $4.66 M(+4.3%) | $17.73 M(+5.9%) |
Jun 2015 | - | $4.47 M(+2.3%) | $16.75 M(+14.4%) |
Mar 2015 | - | $4.37 M(+3.1%) | $14.63 M(+25.5%) |
Dec 2014 | $11.66 M(+281.8%) | $4.24 M(+15.4%) | $11.66 M(+36.9%) |
Sep 2014 | - | $3.67 M(+55.8%) | $8.52 M(+47.3%) |
Jun 2014 | - | $2.36 M(+68.8%) | $5.78 M(+68.8%) |
Mar 2014 | - | $1.40 M(+27.7%) | $3.42 M(+68.8%) |
Dec 2013 | $3.06 M(+229.9%) | $1.09 M(+16.9%) | $2.03 M(+116.9%) |
Sep 2013 | - | $935.00 K | $935.00 K |
Dec 2012 | $926.00 K | - | - |
FAQ
- What is Exagen annual revenue?
- What is the all time high annual revenue for Exagen?
- What is Exagen annual revenue year-on-year change?
- What is Exagen quarterly revenue?
- What is the all time high quarterly revenue for Exagen?
- What is Exagen quarterly revenue year-on-year change?
- What is Exagen TTM revenue?
- What is the all time high TTM revenue for Exagen?
- What is Exagen TTM revenue year-on-year change?
What is Exagen annual revenue?
The current annual revenue of XGN is $52.55 M
What is the all time high annual revenue for Exagen?
Exagen all-time high annual revenue is $52.55 M
What is Exagen annual revenue year-on-year change?
Over the past year, XGN annual revenue has changed by +$6.99 M (+15.33%)
What is Exagen quarterly revenue?
The current quarterly revenue of XGN is $12.51 M
What is the all time high quarterly revenue for Exagen?
Exagen all-time high quarterly revenue is $15.06 M
What is Exagen quarterly revenue year-on-year change?
Over the past year, XGN quarterly revenue has changed by -$909.00 K (-6.78%)
What is Exagen TTM revenue?
The current TTM revenue of XGN is $55.75 M
What is the all time high TTM revenue for Exagen?
Exagen all-time high TTM revenue is $56.66 M
What is Exagen TTM revenue year-on-year change?
Over the past year, XGN TTM revenue has changed by +$4.13 M (+8.00%)